Aquestive Therapeutics, Inc. (AQST) vs Evolus, Inc. (EOLS)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Evolus, Inc. EOLS 7.10 −6.21%
Aquestive Therapeutics, Inc. and Evolus, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. and Evolus, Inc. are of similar size ($509.6M and $500.0M). Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 13.9%. Evolus, Inc. has the higher net margin (−10.9% vs −144.6%) and the lower return on invested capital (−14.5% vs 0.00%). Across the 17 metrics below, Evolus, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | AQST | EOLS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 66.74% | 53.94% |
| Operating margin | (97.52%) | (5.90%) | 0.00% |
| Net margin | (144.63%) | (10.85%) | 0.00% |
| Free cash flow margin | (84.95%) | (6.92%) | 0.00% |
| Return on equity | 121.12% | 138.57% | (0.40%) |
| Return on assets | (69.29%) | (14.40%) | (3.32%) |
| Return on invested capital | 0.00% | (14.47%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack